Infertility Drugs Market

Demand for infertility drugs will increase through 2036, with gonadotrophins at 41.8% of the drug class segment in 2026. The market was valued at USD 4.17 billion in 2025 and is expected to be worth USD 8.17 billion by 2036, creating an incremental opportunity of USD 3.73 billion.